Physician
Cardiology
Dr. James L. Orford, MD
|
|
Give Review
James Orford is an expert in the field of Cardiology. He received awards:"Fellow (FACC)". James Orford is a published MD as well. He has 36 publications published. The latest was: Timing and correlates of very early major adverse clinical events following percutaneous coronary intervention. He is registered with Medicare and accepts Medicare payments.
Publications
- Can N-acetylcysteine reverse the antiplatelet effects of clopidogrel? An in vivo and vitro study.
- Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery.
- Cutting balloon angioplasty vs. conventional balloon angioplasty in patients receiving intraCoronary brachytherapy for the treatment of in-stent restenosis.
- Transport and centralization of Acute coronary syndrome care.
- Alveolar hemorrhage associated with periprocedural eptifibatide administration.
- Increased Th1 activity in patients with Coronary artery disease.
- Routine intravascular ultrasound guidance of percutaneous Coronary intervention: a critical reappraisal.
- Safety and efficacy of aspirin, clopidogrel, and warfarin after Coronary stent placement in patients with an indication for anticoagulation.
- Incidence, correlates, management, and clinical outcome of Coronary perforation: analysis of 16,298 procedures.
- Diabetes mellitus and preferred method of Coronary revascularization--the debate continues.
- Clinical outcome of patients undergoing non-cardiac surgery in the two months following Coronary stenting.
- Safety and efficacy of cutting balloon angioplasty: the Mayo Clinic experience.
- Frequency and correlates of Coronary stent thrombosis in the modern era: analysis of a single center registry.
- Impact of intra-Aortic balloon counterpulsation with different balloon volumes on cardiac performance in humans.
- Anterior ischemia secondary to embolization of the posterior descending Artery in a patient with a chronic total occlusion of the left anterior descending Artery.
- A comparison of the Framingham and European Society of Cardiology coronary Heart disease risk prediction models in the normative aging study.
- GUSTO V: should it affect clinical practice? Global Use of Strategies to Open Occluded Coronary Arteries.
- Rescue percutaneous Coronary intervention following Coronary artery bypass graft--a descriptive analysis of the changing interface between interventional cardiologist ...
- Abciximab readministration.
- Distal protection devices during percutaneous Coronary and carotid interventions.
- Experience with methotrexate, 5-fluorouracil, and leucovorin (MFL): a first line effective, minimally toxic regimen for metastatic breast cancer.
- Pathophysiology of atherosclerosis: development, regression, restenosis.
- Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic Syndromes.
- Manipulating the vascular biology of Coronary atherosclerosis in diabetes: new opportunities.
- Rescue percutaneous Coronary intervention immediately following Coronary artery bypass grafting.
- Clopidogrel.
- Treating ambulatory ischemia in Coronary disease by manipulating the cell biology of atherosclerosis.
- The comparative pathobiology of atherosclerosis and restenosis.
- Timing and correlates of very early major adverse clinical events following percutaneous Coronary intervention.
- Refractory Angina and anterior ischemia in a patient with a patent left internal mammary artery bypass graft.
- Routine intravascular ultrasound scanning guidance of Coronary stenting is not associated with improved clinical outcomes.
- Modulating thrombotic potential in catheter-based percutaneous Coronary and peripheral vascular interventions.
- Clopidogrel inhibits shear-induced platelet function.
- Does clopidogrel increase the degree of platelet inhibition when a platelet glycoprotein IIb/IIIa inhibitor has been given? Insights from an optical platelet aggregome...
- Differences in human antioxidized LDL autoantibodies in patients with stable and unstable Angina.
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Mayo School of Graduate Medical Education -
Brigham and Women's Hospital -
University of Cape Town Faculty of Medicine
Hospital
-
Intermountain Medical Center
Drug Facts
| NPI NUMBER | 1902843931 | |
| NPPES Provider LastName | ORFORD | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 826012704 | |
| NPPES Provider State | WY | |
| Specialty Description | Cardiology | |
| Total Claim Count | 890.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1902843931 |
| Last Name Of The Provider | ORFORD |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Kent G. Meredith, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Rex A. Outtrim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian K. Whisenant, MD
This Doctor is OpenDoctor Recommended.
|